Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies
Ganesha Rai(National Institutes of Health), Theodore R. Holman(University of California, Santa Cruz), Victor Kenyon(Amgen (United States)), Giovanni Diaz(University of California, Santa Cruz), Qiangli Zhang(University of California, Santa Cruz), Anton Simeonov(National Institutes of Health), Ajit Jadhav(National Institutes of Health), Lena Schultz(National Institutes of Health), Klaus van Leyen(Harvard University), Steve Perry(University of California, Santa Cruz), David J. Maloney(National Institutes of Health), Eng H. Lo(Harvard University), Yu Liu(Soochow University), Netra Joshi(University of California, Santa Cruz), Joo Eun Jung(The University of Texas Health Science Center at Houston), Adam Yasgar(National Institutes of Health)
Cited by 98
Related Papers
The Science of Stroke: Mechanisms in Search of Treatments
|Neuron|2010|1.9k
Mechanisms, challenges and opportunities in stroke
|Nature reviews. Neuroscience|2003|1.8k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k